GGrantIndex
Sort

4,870 grants matching glp 1

Functional and Behavioral Characterization of Central Amygdala Glucagon Like Peptode-1 Receptors

$111,375
James Andrew Hardaway · University Of Alabama At Birmingham · R03 · FY2022 · DK

CORE--MICROARRAY &ANALYSIS SHARED SERVICE

$111,132
University Of Pittsburgh At Pittsburgh · P30 · FY2004 · CA

Growth and development of islets and beta-cells in the pancreas

$109,867
Vipul Periwal · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK

Core D: Drug Development

$109,264
Heidi M. Mansour · University Of Arizona · P01 · FY2023 · CA

Ambient light activatable opsin based therapy for age-related macular degeneration

$109,200
Samarendra Kumar Mohanty · Nanoscope Technologies, Llc · R44 · FY2019 · EY

Rapid Sampling for Resistant S. Pneumonaie in Guatemala

$108,535
Erica Lynn Dueger · Johns Hopkins University · K01 · FY2006 · TW

Enhancing Weight Loss Maintenance with GLP-1 in Adolescents with Severe Obesity

$108,528
Aaron S Kelly · University Of Minnesota · R01 · FY2015 · DK

Analytical Pharmacology Core

$108,497
Timothy W Synold · Beckman Research Institute/City Of Hope · P30 · FY2019 · CA

Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide N-Methyl Dichloropropionaniline

$108,153
John B Barnett · Exesalibero, Inc. · R42 · FY2020 · AR

Hematopoietic Biorepository and Cellular Therapy Shared Resource

$107,656
David Wald · Case Western Reserve University · P30 · FY2023 · CA

Hematopoietic Biorepository and Cellular Therapy Shared Resource

$107,656
David Wald · Case Western Reserve University · P30 · FY2024 · CA

Smart CSF Delivery System for CNS Drug Therapy for Leptomeningeal Disease

$107,649
Marcie A Glicksman · Enclear Therapies, Inc. · R43 · FY2025 · CA

Beta-Cell Rest in Adolescents and Young Adults with Type 2 Diabetes (07-DK-0115)

$107,590
James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK

Translational Studies: IND enabling studies.

$107,215
Tian J. Yang · Global Alliance For Tb Drug Development · U19 · FY2019 · AI

Core D: Drug Development

$107,161
Heidi M. Mansour · University Of Arizona · P01 · FY2021 · CA

Development of MIDI-Ray Implant for Glaucoma

$106,994
Leonard Pinchuk · Innfocus, Llc · R43 · FY2008 · EY

Glucagon-like peptide-1 modulation of alcohol effects

$106,279
Simon Barak Caine · Mclean Hospital · R01 · FY2017 · AA

Secretagogue induced mechanisms regulating islet electrical activity

$106,154
David Aaron Jacobson · University Of Chicago · K01 · FY2009 · DK

University of Maryland, Baltimore Biomarker Reference Laboratory

$106,067
Sanford A Stass · University Of Maryland Baltimore · U24 · FY2015 · CA

Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions

$105,977
Nira Ben-Jonathan · University Of Cincinnati · U01 · FY2011 · ES

Scientific Core

$105,199
Tim Mosmann · University Of Rochester · U19 · FY2013 · AI

Development of Dual GABAA and alpah7 Nicotinic Receptor Modulators for AD

$105,100
Kelvin W Gee · University Of California-Irvine · U01 · FY2010 · AG

Targeting chemoresistant prostate cancer with novel EED inhibitors

$104,961
Daqing Wu · Clark Atlanta University · R01 · FY2024 · CA

Core D: Drug Development

$104,734
Heidi M. Mansour · University Of Arizona · P01 · FY2022 · CA

Glucagon-like peptide-1 modulation of alcohol effects

$104,306
Morgane Hermann Thomsen · Region Hovedstaden · R01 · FY2022 · AA